Literature DB >> 11819033

Anoxia redistributes adenosine A(2A) receptors in PC12 cells and increases receptor-mediated formation of cAMP.

Giulia Arslan1, Björn Kull, Bertil B Fredholm.   

Abstract

Abstract. Undifferentiated and NGF-treated PC12 cells were subjected to anoxia for up to 24 h. The adenosine A(2A) receptor antagonist 5-amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo[4,3-e]-1,2,4 triazolo[1,5-c]pyrimidine (SCH 58261) decreased viability of undifferentiated, but not NGF-treated PC12 cells after 6 h of anoxia. Anoxia also transiently enhanced cAMP responses induced via activation of adenosine A(2A) receptors in undifferentiated PC12 cells (20-fold decrease in the EC(50) value for the agonist 2-[ p-(2-carbonylethyl) phenylethylamino]-5'- N-ethylcarboxamidoadenosine, CGS 21680). In NGF-treated PC12 cells, by contrast, anoxia decreased both the maximal response to and the potency of CGS 21680. In undifferentiated PC12 cells subjected to anoxia a very modest increase of A(2A) receptor mRNA was detected in cells by Northern blotting, but no changes in the amount of the receptor protein could be seen by Western blotting. However, surface biotinylation of the cells followed by avidin pull-down showed that the A(2A) receptor at the cell membrane was increased after anoxia. This was supported by immunolabelling of the A(2A) receptors: much of the receptor protein was present in the cytoplasm of normoxic cells, but in cells subjected to anoxia the A(2A) receptor immunolabelling at the cell membrane was more pronounced, indicating redistribution of the receptors from intracellular pools to the cell membrane during anoxia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11819033     DOI: 10.1007/s002100100456

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  12 in total

1.  [MUV Researcher of the Month, October 2014].

Authors:  Christian Bergmayr
Journal:  Wien Klin Wochenschr       Date:  2014-10       Impact factor: 1.704

2.  Adenosine A2A receptor in the monkey basal ganglia: ultrastructural localization and colocalization with the metabotropic glutamate receptor 5 in the striatum.

Authors:  James W Bogenpohl; Stefanie L Ritter; Randy A Hall; Yoland Smith
Journal:  J Comp Neurol       Date:  2012-02-15       Impact factor: 3.215

3.  Adenosine A2A receptor and ecto-5'-nucleotidase/CD73 are upregulated in hippocampal astrocytes of human patients with mesial temporal lobe epilepsy (MTLE).

Authors:  Aurora R Barros-Barbosa; Fátima Ferreirinha; Ângela Oliveira; Marina Mendes; M Graça Lobo; Agostinho Santos; Rui Rangel; Julie Pelletier; Jean Sévigny; J Miguel Cordeiro; Paulo Correia-de-Sá
Journal:  Purinergic Signal       Date:  2016-09-20       Impact factor: 3.765

4.  Binding of the prototypical adenosine A(2A) receptor agonist CGS 21680 to the cerebral cortex of adenosine A(1) and A(2A) receptor knockout mice.

Authors:  Luísa V Lopes; Linda Halldner; Nelson Rebola; Björn Johansson; Catherine Ledent; Jian Fan Chen; Bertil B Fredholm; Rodrigo A Cunha
Journal:  Br J Pharmacol       Date:  2004-03-01       Impact factor: 8.739

5.  Wheel running alters patterns of uncontrollable stress-induced cfos mRNA expression in rat dorsal striatum direct and indirect pathways: A possible role for plasticity in adenosine receptors.

Authors:  Peter J Clark; Parsa R Ghasem; Agnieszka Mika; Heidi E Day; Jonathan J Herrera; Benjamin N Greenwood; Monika Fleshner
Journal:  Behav Brain Res       Date:  2014-07-11       Impact factor: 3.332

6.  Differential Expression of Adenosine P1 Receptor ADORA1 and ADORA2A Associated with Glioma Development and Tumor-Associated Epilepsy.

Authors:  Jun Huang; Ming-Na Chen; Juan Du; Hao Liu; Yu-Jiao He; Guo-Liang Li; Shu-Yu Li; Wei-Ping Liu; Xiao-Yan Long
Journal:  Neurochem Res       Date:  2016-04-02       Impact factor: 3.996

7.  Chaperoning of the A1-adenosine receptor by endogenous adenosine - an extension of the retaliatory metabolite concept.

Authors:  Justyna Kusek; Qiong Yang; Martin Witek; Christian W Gruber; Christian Nanoff; Michael Freissmuth
Journal:  Mol Pharmacol       Date:  2014-10-29       Impact factor: 4.436

8.  Static magnetic field exposure reproduces cellular effects of the Parkinson's disease drug candidate ZM241385.

Authors:  Zhiyun Wang; Pao-Lin Che; Jian Du; Barbara Ha; Kevin J Yarema
Journal:  PLoS One       Date:  2010-11-08       Impact factor: 3.240

9.  Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade.

Authors:  Rodrigo A Cunha
Journal:  Purinergic Signal       Date:  2005-03-17       Impact factor: 3.765

10.  Recruitment of a cytoplasmic chaperone relay by the A2A adenosine receptor.

Authors:  Christian Bergmayr; Patrick Thurner; Simon Keuerleber; Oliver Kudlacek; Christian Nanoff; Michael Freissmuth; Christian W Gruber
Journal:  J Biol Chem       Date:  2013-08-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.